skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing

Journal Article · · J. Clin. Invest.; (United States)
DOI:https://doi.org/10.1172/JCI111660· OSTI ID:5829077

Soluble antibody//sub 3/H-double-stranded PM2 DNA (dsDNA) immune complexes were briefly opsonized with complement and then allowed to bind to human erythrocytes (via complement receptors). The cells were washed and subsequently a volume of autologous blood in a variety of media was added, and the release of the bound immune complexes from the erythrocytes was studied as a function of temperature and time. After 1-2 h, the majority of the bound immune complexes were not released into the serum during blood clotting at either 37 degrees C or room temperature, but there was a considerably greater release of the immune complexes into the plasma of blood that was anticoagulated with EDTA. Similar results were obtained using various conditions of opsonization and also using complexes that contained lower molecular weight dsDNA. Thus, the kinetics of release of these antibody/dsDNA immune complexes differed substantially from the kinetics of release of antibody/bovine serum albumin complexes that was reported by others. Studies using the solution phase C1q immune complex binding assay confirmed that in approximately half of the SLE samples that were positive for immune complexes, there was a significantly higher level of detectable immune complexes in plasma vs. serum. Freshly drawn erythrocytes from some SLE patients exhibiting this plasma/serum discrepancy had IgG antigen on their surface that was released by incubation in EDTA plasma. Thus, the higher levels of immune complexes observed in EDTA plasma vs. serum using the C1q assay may often reflect the existence of immune complexes circulating in vivo bound to erythrocytes.

Research Organization:
Univ. of Virginia, Charlottesville, VA (United States)
OSTI ID:
5829077
Journal Information:
J. Clin. Invest.; (United States), Vol. 75:1
Country of Publication:
United States
Language:
English

Similar Records

The alternative complement pathway control protein H binds to immune complexes and serves their detection
Journal Article · Sat Jan 01 00:00:00 EST 1983 · Clin. Immunol. Immunopathol.; (United States) · OSTI ID:5829077

Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus
Journal Article · Sun Mar 01 00:00:00 EST 1987 · Medicine (Baltimore); (United States) · OSTI ID:5829077

Decreased complement mediated binding of antibody//sup 3/-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies
Journal Article · Wed Jun 01 00:00:00 EDT 1983 · Arthritis Rheum.; (United States) · OSTI ID:5829077